Literature DB >> 17705167

High diversity of HHV-8 molecular subtypes in the Amazon region of Brazil: evidence of an ancient human infection.

Marluísa de Oliveira Guimarães Ishak1, Rosimar Neris Martins, Paula Renata Lima Machado, Lia Lobato Batista de Souza, Luiz Fernando Almeida Machado, Vânia Nakauth Azevedo, Harutaka Katano, Tetsutaro Sata, Hideki Hasegawa, Antonio Carlos Rosário Vallinoto, Ricardo Ishak.   

Abstract

The present study describes the molecular epidemiology of Human herpesvirus 8 (HHV-8) among four Indian tribes (Kararao, Arara Laranjal, Tiriyo, and Zo'e) of the Amazon region of Brazil and a group of HIV-1-infected subjects from the urban population of Belem, Para. Infection was characterized by the presence of antibodies using ELISA (measuring antibodies to ORF59, ORF65, K8.1A, K8.1B, and ORF73), and molecular assays (gene amplification of the regions ORF26 and the variable region VR1). Antibodies to HHV-8 were detected in 66 samples of the 221 Brazilian Amerindians, namely, 6 (25%) in the Kararao, 18 (19.6%) in the Arara Laranjal, 24 (42.9%) in the Tiriyo, and 18 (36.7%) in the Zo'e. Among the 477 HIV-1-infected subjects, antibodies to HHV-8 were present in 74 (15.5%) persons. The ORF26 region was amplified in seven samples, one of the Arara Laranjal, one of the Tiriyo, two of the Zo'e, and three of the HIV-1-infected group. Subtyping of HHV-8 described a high multiplicity of molecular subtypes, including C (Zo'e), E (Tiriyo), and B (HIV-1 infected). Serological results confirm the high prevalence of HHV-8 among Amerindians and the presence of three subtypes in the Amazon region of Brazil, including a unique subtype, which favors the idea of HHV-8 as an ancient human infection within this particular geographical region. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17705167     DOI: 10.1002/jmv.20995

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  6 in total

1.  Seroprevalence of Kaposi's sarcoma-associated herpesvirus and risk factors in Xinjiang, China.

Authors:  Bishi Fu; Feng Sun; Baolin Li; Lei Yang; Yan Zeng; Xiulian Sun; Fanhong Xu; Simon Rayner; Moraima Guadalupe; Shou-Jiang Gao; Linding Wang
Journal:  J Med Virol       Date:  2009-08       Impact factor: 2.327

2.  Variations in human herpesvirus type 8 seroprevalence in Native Americans, South America.

Authors:  Vanda A U F Souza; Francisco M Salzano; Maria Luiza Petzl-Erler; Maria Claudia Nascimento; Philippe Mayaud; Jaila Dias Borges; Claudio S Pannuti
Journal:  Emerg Infect Dis       Date:  2010-06       Impact factor: 6.883

3.  Human herpesvirus 8 genotype E in patients with Kaposi sarcoma, Peru.

Authors:  Olivier Cassar; Marie Lise Blondot; Salim Mohanna; Gregory Jouvion; Francisco Bravo; Vicente Maco; Renan Duprez; Michel Huerre; Eduardo Gotuzzo; Antoine Gessain
Journal:  Emerg Infect Dis       Date:  2010-09       Impact factor: 6.883

4.  Genotypic distribution of HHV-8 in AIDS individuals without and with Kaposi sarcoma: Is genotype B associated with better prognosis of AIDS-KS?

Authors:  Tania Regina Tozetto-Mendoza; Karim Yaqub Ibrahim; Adriana Fumie Tateno; Cristina Mendes de Oliveira; Laura Massami Sumita; Maria Carmem Arroyo Sanchez; Expedito José Luna; Ligia Camara Pierrotti; Jan Felix Drexler; Paulo Henrique Braz-Silva; Claudio Sérgio Pannuti; Camila Malta Romano
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

Review 5.  Infectious Agents As Markers of Human Migration toward the Amazon Region of Brazil.

Authors:  Ricardo Ishak; Luiz F A Machado; Izaura Cayres-Vallinoto; Marluísa de O Guimarães Ishak; Antonio C R Vallinoto
Journal:  Front Microbiol       Date:  2017-08-31       Impact factor: 5.640

6.  Seroepidemiology and phylogenetic analysis of human herpesvirus type 8 in injection drug users and men who have sex with men in northern Taiwan.

Authors:  Yuan-Ming Lee; Pei-Shih Hung; Cheng-Wen Lin
Journal:  J Int Med Res       Date:  2018-03-29       Impact factor: 1.671

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.